logo-loader
RNS
National Milk Records

National Milk Recrds - Directorate Change

RNS Number : 7912H
National Milk Records PLC
27 March 2020
 

27th March 2020

 

NATIONAL MILK RECORDS PLC

("NMR", the "Company", or, together with its subsidiaries, the "Group")

Directorate Change

National Milk Records plc (NMR), the leading supplier of dairy and livestock information services, is pleased to announce the appointment of Dr James Andrews as a Non-Executive Director of the Company as of 26th March 2020.

Dr Andrews has significant experience within the dairy, pharmaceuticals, financial services and consumer goods industries, spanning over 13 years and three continents, including positions at Bain & Company and Felcana. His surgical veterinary experience is valuable to NMR where livestock is central to our key business areas.

Dr Andrews is currently the CEO and Director of Felcana, a company that helps empower vets with data analysis and tools to treat disease more effectively. Additionally, he works as a freelance strategy consultant where his achievements include leading the five-year strategy development and implementation planning for a leading UK dairy business. Also, in a consulting capacity, Dr Andrews was responsible for revising the product strategy for a US-based food security business resulting in a move away from hardware sales into SaaS.

Dr Andrews' comprehensive education includes a Bachelor of Veterinary Medicine and Surgery from the University of Edinburgh, in his final year he attended the Norwegian Veterinary School where he undertook a four-month ERASMUS to participate in clinical rotations. Additionally, Dr Andrews, completed his masters at INSEAD Business School in France, where he was also a member of the Entrepreneurial, Healthcare and Energy Clubs.

In his position as Non-Executive Director at National Milk Records, Dr Andrews will take on the Chair of the Strategy Committee.

Trevor Lloyd, Chairman, commented:

"It is with great pleasure that, on behalf of the Board, I welcome James to the Company. James has demonstrated his ability to lead and think outside of the box throughout his successful career. His veterinary, dairy, disease treatment and Information Technology expertise will prove invaluable to National Milk Records as we look to continue our growth strategy.

"I believe that his appointment will strengthen NMR and I look forward to working with James and to his future contributions to the Company."

Dr James Aloysius Andrews is, or has been, a member or partner of the administrative, management or supervisory bodies for the below companies and partnerships during the past three years:

Current

Previous

Pet Technology Limited (T/A Felcana)

Andrews Advisory Limited

-

 

There is no further information required to be disclosed pursuant to Rule 66 and Appendix 1, Table A, paragraph 5.1.2 of the AQSE Growth Market - Rules for Issuers.

For further information please contact:

National Milk Records plc

Andy Warne, Managing Director

Mark Frankcom, Finance Director

 

 

+44 7970 009 141
+44 7458 002 444

Canaccord Genuity

Adam James

Georgina McCooke

 

+44 20 7523 8000

Blytheweigh (Financial PR)

Megan Ray

Rachael Brooks

+44 20 7138 3204

 

About NMR

NMR is the leading supplier of essential management information to the UK dairy supply chain. Through a team of self-employed milk-recorders, it collects and tests milk samples for approximately 50% of the UK's two million cows. In addition, its laboratories provide payment testing and disease testing services for Britain's milk processors. NMR has a joint-venture laboratory in the Republic of Ireland providing similar services to farmers and processors across the whole of Ireland. Another division of the Group is a livestock traceability business, Nordic Star, which services the UK dairy and beef sectors.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NEXEANDKAAPEEFA
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read